title: Risk stratification and patient counseling for natalizumab in multiple sclerosis.
authors.affiliation: Department of Neurology and Neurological Institute, ClevelandClinic, Cleveland, OH, USA. foxr@ccf.org
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Fox
authors.forename: Richard A
authors.initials: RA
authors.lastname: Rudick
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D003376:Counseling; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D012306:Risk
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab